The germline variant <i>CTLA4</i> rs231775 polymorphism may alter T-cell function and affect clinical outcomes.<h4>Methods</h4>We conducted a retrospective single-center study including 156 consecutive myeloma patients who underwent first-line ASCT. The gene discussed is CTLA4; the disease is plasma cell myeloma.